Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases

MLA

Teng Moua, et al. “Healthcare Utilisation and Costs in the Diagnosis and Treatment of Progressive-Fibrosing Interstitial Lung Diseases.” European Respiratory Review, vol. 27, Dec. 2018, p. 180078. EBSCOhost, https://doi.org/10.1183/16000617.0078-2018.

APA

Teng Moua, Fabrizio Luppi, Mary Beth Scholand, Colin Holtze, Carlo Vancheri, Michael Kreuter, & Kevin R. Flaherty. (2018). Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases. European Respiratory Review, 27, 180078. https://doi.org/10.1183/16000617.0078-2018

Chicago

Teng Moua, Fabrizio Luppi, Mary Beth Scholand, Colin Holtze, Carlo Vancheri, Michael Kreuter, and Kevin R. Flaherty. 2018. “Healthcare Utilisation and Costs in the Diagnosis and Treatment of Progressive-Fibrosing Interstitial Lung Diseases.” European Respiratory Review 27 (December): 180078. doi:10.1183/16000617.0078-2018.